P. Ockelford

发表

The influences of obesity and glycemic control on endothelial activation in patients with type 2 diabetes.

G. Gamble, W. Bagg, G. Desideri, 2001, The Journal of clinical endocrinology and metabolism.

The Diagnosis of Acute, Recurrent, Deep‐vein Thrombosis: A Diagnostic Challenge

M. Gent, P. Powers, A. Turpie, 1983, Circulation.

Edoxaban for treatment of venous thromboembolism in patients with cancer

G. Raskob, H. Büller, M. Mercuri, 2015, Thrombosis and Haemostasis.

Fixed-Dose, Weight-Adjusted, Unfractionated Heparin (UFH) Given Subcutaneously (sc) without Laboratory Monitoring for Acute Treatment of Venous Thromboembolism (VTE): Randomized Comparison with Low-Molecular-Weight-Heparin (LMWH).

J. Douketis, J. Hirsh, M. Gent, 2004 .

Discordance between the anti-Xa activity and the antithrombotic activity in an ultra-low molecular weight heparin fraction.

J. Hirsh, L. Mitchell, P. Ockelford, 1982, Thrombosis research.

USE OF A NEW HEPARINOID AS ANTICOAGULANT DURING ACUTE HAEMODIALYSIS OF PATIENTS WITH BLEEDING COMPLICATIONS

H. Cate, P. Ockelford, C. Henny, 1983, The Lancet.

Etiology, prognosis, and hemostatic function after cerebral infarction in young adults.

P. Ockelford, A. Chancellor, G. Glasgow, 1989, Stroke.

Comparison of the in vivo hemorrhagic and antithrombotic effects of a low antithrombin-III affinity heparin fraction.

J. Hirsh, C. Carter, P. Ockelford, 1982, Thrombosis research.

How we use recombinant activated Factor VII in patients with haemophilia A or B complicated by inhibitors

S. Brown, C. Barnes, S. Dunkley, 2012, Internal medicine journal.

Posttreatment ultrasound-detected residual venous thrombosis: a risk factor for recurrent venous thromboembolism and mortality

P. Ockelford, P. Harper, L. Savory, 2007, Current opinion in pulmonary medicine.

Audit of community‐based anticoagulant monitoring in patients with thromboembolic disease: is frequent testing necessary?

P. Ockelford, P. Harper, L. Young, 2004, Internal medicine journal.

Reduced synthesis of tissue plasminogen activator by vascular endothelium during acute myocardial infarction.

H. White, M. Takayama, R. Norris, 1992, Australian and New Zealand journal of medicine.

A Double-Blind Randomized Placebo Controlled Trial of Thromboprophylaxis in Major Elective General Surgery Using Once Daily Injections of a Low Molecular Weight Heparin Fragment (Fragmin)

P. Ockelford, J. Patterson, A. Johns, 1989, Thrombosis and Haemostasis.

D‐dimer concentration increases with age reducing the clinical value of the D‐dimer assay in the elderly

P. Ockelford, P. Harper, E. Theakston, 2007, Internal medicine journal.

Haemophilia B Leyden arising de novo by point mutation in the putative factor IX promoter region

P. Browett, P. Ockelford, G. Royle, 1991, British journal of haematology.

Post‐treatment residual thrombus increases the risk of recurrent deep vein thrombosis and mortality

D. Milne, S. Mckelvie, P. Ockelford, 2006, Journal of thrombosis and haemostasis : JTH.

Outcome of abnormal impedance plethysmography results in patients with proximal-vein thrombosis: frequency of return to normal.

J. Hirsh, H. Buller, A. Turpie, 1984, Thrombosis research.

Evaluation of impedance plethysmography as a single non-invasive test for the diagnosis of clinically suspected deep vein thrombosis.

H. Büller, J. T. ten Cate, M. Huisman, 1984, The Netherlands journal of medicine.

Two Weeks of Low Molecular Weight Heparin for Isolated Symptomatic Distal Vein Thrombosis (TWISTER study).

B. Chong, Mark E. Smith, S. Mcrae, 2021, Thrombosis research.

The challenge arising from the cost of haemophilia care: an audit of haemophilia treatment at Auckland Hospital.

P. Ockelford, P. Harper, L. Teague, 2003, The New Zealand medical journal.

Transformation of essential thrombocythaemia to T cell acute lymphoblastic leukaemia.

P. Ockelford, P. Browett, L. Berkahn, 1996, Leukemia & lymphoma.

The use of a co‐design model in improving timely bleed reporting by adults with haemophilia living in the Auckland region of New Zealand

P. Ockelford, L. Young, S. Preston, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

Deep vein thrombosis prophylaxis: a survey of current practice in Australia and New Zealand.

P. Ockelford, J. Fletcher, J. Koutts, 1992, The Australian and New Zealand journal of surgery.

Influence of heat treatment on FVIII:C recovery from freeze dried cryoprecipitate.

D. Woodfield, P. Ockelford, A. Johns, 1988, Journal of clinical pathology.

Heparin 1986. Indications and effective use.

P. Ockelford, 1986, Drugs.

Management of Venous Thrombosis and Thrombophlebitis

R. Hull, P. Ockelford, 1982, Drugs.

Two missense mutations identified in venous thrombosis patients impair the inhibitory function of the protein Z dependent protease inhibitor

P. Browett, P. Coughlin, P. Harper, 2012, Thrombosis and Haemostasis.

Clinical experience with arginine vasopressin (DDAVP) in von Willebrand's disease and mild haemophilia.

P. Ockelford, N. Menon, E. Berry, 1980, The New Zealand medical journal.

Consensus guidelines for warfarin therapy: Recommendations from the Australasian Society of Thrombosis and Haemostasis

B. Chong, A. Street, A S Gallus, 2000, The Medical journal of Australia.

Challenges in hemophilia care in Australia and New Zealand

S. McRae, S. Brown, C. Barnes, 2015, Current medical research and opinion.

Chronic arthropathy management in haemophilia: assessing the impact of a new model of care.

P. Ockelford, L. Young, M. Brasser, 2012, The New Zealand medical journal.

Neonatal antithrombin III

M. Peters, P. Ockelford, J. Cate, 1984, British journal of haematology.

Serological complications of a major ABO incompatible bone marrow transplantation in a Polynesian with aplastic anemia

D. Woodfield, H. Blacklock, P. Ockelford, 1982, Transfusion.

Diagnosis and treatment of MYH9-RD in an Australasian cohort with thrombocytopenia

M. Morel-Kopp, C. Ward, B. Kile, 2018, Platelets.

Lidocaine and the reduction of post-venographic pain.

J. Hirsh, M. Gent, P. Powers, 1984, Australian and New Zealand journal of medicine.

A 20.7 kb Deletion within the Factor VIII Gene Associated with LINE-1 Element Insertion

P. Browett, Ruth R. E. Williams, P. Ockelford, 1998, Thrombosis and Haemostasis.

A comparison of the antithrombotic and haemorrhagic effects of low molecular weight heparin fractions: the influence of the method of preparation.

J. Hirsh, B. Boneu, M. Buchanan, 1984, Thrombosis research.

Comparative separation of human plasma proteins on polysulphated chromatographic media.

P. Ockelford, A. Benny, J. Preston, 1988, Thrombosis research.

Mutations within the protein Z‐dependent protease inhibitor gene are associated with venous thromboembolic disease: a new form of thrombophilia

P. Browett, P. Harper, P. Ockelford, 2004, British journal of haematology.

Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan.

C J Carter, G. Raskob, D. Doyle, 1983, Annals of internal medicine.

Identification of a contaminant protein in the purification of human factor V. Comparison of two purification methods.

J. T. ten Cate, A. Sturk, T. Bruin, 1983, Biochimica et biophysica acta.

Clinical manifestations of the thrombocytopenia and absent radii (TAR) syndrome.

R. Nicol, P. Ockelford, D. Gounder, 1989, Australian and New Zealand journal of medicine.

Haemoglobin Manukau β67[E11] Val→Gly: transfusion‐dependent haemolytic anaemia ameliorated by coexisting alpha thalassaemia

S. Brennan, R. Trent, D. Boswell, 1993, British journal of haematology.

Factor IX gene mutations in haemophilia B: a New Zealand population‐based study

Ruth Williams, P. Browett, P. Ockelford, 1996, Haemophilia : the official journal of the World Federation of Hemophilia.

Restriction fragment length polymorphisms associated with the factor VIII and factor IX genes in Polynesians.

P. Ockelford, D. Ridgway, N. S. Van-De-Water, 1991, Journal of medical genetics.

Bone marrow transplantation in a child with acute lymphoblastic leukaemia.

D. Woodfield, H. Blacklock, P. Ockelford, 1980, The New Zealand medical journal.

Improved survival from acute lymphoblastic leukemia in adolescents and adults

J. G. Buchanan, H. Blacklock, P. Ockelford, 1981, Cancer.

Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism.

J. Douketis, J. Hirsh, M. Gent, 2006, JAMA.

Hydroxyurea induced skin ulceration in myeloproliferative disorders.

P. Ockelford, C. McLintock, 2000, Australian and New Zealand journal of medicine.

Diagnostic efficacy of impedance plethysmography for clinically suspected deep-vein thrombosis. A randomized trial.

Denise H. Kinch, J. Hirsh, H. Büller, 2020, Annals of internal medicine.

Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.

G. Raskob, J. Hirsh, M. Gent, 1982, The New England journal of medicine.

Comparison of Fixed-Dose Weight-Adjusted Unfractionated Heparin and Low-Molecular- Weight Heparin for Acute Treatment of Venous Thromboembolism

J. Douketis, J. Hirsh, M. Gent, 2006 .

Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group.

P. Bossuyt, M. Prins, H. Büller, 1996, The New England journal of medicine.

Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis

J. Douketis, W. Ageno, F. Dentali, 2013, Thrombosis and Haemostasis.

Low-dose aspirin for preventing recurrent venous thromboembolism.

D. Xavier, J. Eikelboom, J. Simes, 2012, The New England journal of medicine.

Survival in patients with malignancy and venous thromboembolism by tumour subtype and thrombus location

T. Prestidge, P. Ockelford, P. Harper, 2012, Internal medicine journal.

Pulmonary embolism following placement of a Greenfield Filter.

P. Ockelford, J. Wattie, P. Charlesworth, 1989, Australian and New Zealand journal of medicine.

Controlled Pore Glass Factor VIII Concentrate: Influence of Heat Treatment

D. Woodfield, P. Ockelford, A. Johns, 1987, Pathology.

Real‐world experience with limited screening for occult malignancy in patients presenting with spontaneous venous thromboembolism: a single‐centre, retrospective cohort study

P. Ockelford, L. Young, Brian T. Grainger, 2022, Internal medicine journal.

Orgaran (Org 10172) or Heparin for Preventing Venous Thrombosis after Elective Surgery for Malignant Disease? A Double-Blind, Randomised, Multicentre Comparison

H. Magnani, P. Ockelford, A. Gallus, 1993, Thrombosis and Haemostasis.

BENEFICIAL EFFECT OF D.D.A.V.P. ON BLEEDING-TIME IN VON WILLEBRAND'S DISEASE

P. Ockelford, E. Berry, C. Menon, 1978, The Lancet.

Screening for a prothrombotic diathesis in patients attending family planning clinics.

P. Ockelford, N. S. Van de Water, T. Day, 1999, The New Zealand medical journal.

Hemoglobin Volga, β27 (B9) Ala→Asp: Functional and Clinical Correlations of an Unstable Hemoglobin

R. Carrell, S. Brennan, M. Vissers, 1980 .

The Lack Of Relationship Between Anti-Xa Activity And Antithrombotic Activity Of Low Molecular Weight Heparin

J. Hirsh, P. Ockelford, C. Carter, 1981, Thrombosis and Haemostasis.

IN VIVO ACTIVITY OF A NEW HEPARINOID

J. Hirsh, P. Ockelford, C. Carter, 1985, Pathology.

A double-blind placebo controlled trial to study the efficacy and safety of a low molecular weight heparin fragment (fragmin) in patients having major elective general surgery

P. Ockelford, J. Patterson, A. Johns, 1987 .

Disseminated Intravascular Coagulation: The Application and Utility of Diagnostic Tests

P. Ockelford, C. Carter, 1982, Seminars in thrombosis and hemostasis.

Extramedullary haematopoiesis (EMH) complicating HbE-beta thalassaemia.

P. Ockelford, D. Ruttenberg, S. Halfpenny, 1997, Australian and New Zealand Journal of Medicine.

Novel Fibrinogen Truncation with Deletion of Bβ Chain Residues 440-461 causes Hypofibrinogenaemia

S. Brennan, P. George, P. Ockelford, 2002, Thrombosis and Haemostasis.

Edoxaban for treatment of venous thromboembolism in patients with cancer

G. Raskob, H. Büller, M. Mercuri, 2015, Thrombosis and Haemostasis.

Separation of vitamin K-dependent coagulation factors on sulphated cellulose.

C. Brimer, P. Ockelford, A. K. Morgan, 1989, Journal of chromatography.

Bahrain health workers in danger: call to action.

P. Ockelford, B. Gray, 2011, The New Zealand medical journal.